(SITM) Sitime - Overview
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US82982T1060
Stock: Resonators, Clock Oscillators, Silicon Timing
Total Rating 70
Risk 82
Buy Signal 1.09
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 69.1% |
| Relative Tail Risk | -10.2% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.42 |
| Alpha | 55.20 |
| Character TTM | |
|---|---|
| Beta | 2.465 |
| Beta Downside | 2.554 |
| Drawdowns 3y | |
|---|---|
| Max DD | 55.26% |
| CAGR/Max DD | 0.91 |
Description: SITM Sitime January 08, 2026
SiTime Corporation (NASDAQ:SITM) designs, develops, and sells silicon-based timing solutions-including resonators, clock ICs, and oscillators-to a broad set of end-markets such as communications, data centers, automotive, IoT, and aerospace & defense. Headquartered in Santa Clara, California, the firm operates globally across Taiwan, Hong Kong, the United States, Singapore and other regions.
Key quantitative signals (as of the most recent filings) show SiTime’s FY 2024 revenue grew ~28% YoY to roughly $215 million, with gross margins expanding to 55% driven by higher-margin clock-IC sales. The timing-chip market is being propelled by two macro trends: (1) the explosion of AI-driven data-center workloads that require sub-nanosecond synchronization, and (2) the rollout of 5G and advanced driver-assist systems (ADAS) that demand ultra-precise, low-power timing modules. SiTime’s addressable market is estimated at $4-5 billion, giving the company a modest but growing niche share.
For a deeper quantitative assessment, you may want to explore ValueRay’s detailed model on SiTime.
Piotroski VR‑10 (Strict, 0-10) 2.0
| Net Income: -42.9m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.02 > 0.02 and ΔFCF/TA 1.15 > 1.0 |
| NWC/Revenue: 264.9% < 20% (prev 214.9%; Δ 49.98% < -1%) |
| CFO/TA 0.06 > 3% & CFO 75.3m > Net Income -42.9m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 11.30 > 1.5 & < 3 |
| Outstanding Shares: last quarter (27.1m) vs 12m ago 15.35% < -2% |
| Gross Margin: 53.57% > 18% (prev 0.52%; Δ 5305 % > 0.5%) |
| Asset Turnover: 29.97% > 50% (prev 22.90%; Δ 7.07% > 0%) |
| Interest Coverage Ratio: -3.84 > 6 (EBITDA TTM -26.7m / Interest Expense TTM -14.9m) |
Altman Z'' 1.76
| A: 0.67 (Total Current Assets 949.3m - Total Current Liabilities 84.0m) / Total Assets 1.29b |
| B: -0.17 (Retained Earnings -224.9m / Total Assets 1.29b) |
| C: -0.05 (EBIT TTM -57.2m / Avg Total Assets 1.09b) |
| D: -1.62 (Book Value of Equity -224.9m / Total Liabilities 138.5m) |
| Altman-Z'' Score: 1.76 = BBB |
Beneish M -3.15
| DSRI: 0.73 (Receivables 45.0m/38.2m, Revenue 326.7m/202.7m) |
| GMI: 0.96 (GM 53.57% / 51.55%) |
| AQI: 0.64 (AQ_t 0.18 / AQ_t-1 0.28) |
| SGI: 1.61 (Revenue 326.7m / 202.7m) |
| TATA: -0.09 (NI -42.9m - CFO 75.3m) / TA 1.29b) |
| Beneish M-Score: -3.15 (Cap -4..+1) = AA |
What is the price of SITM shares?
As of February 07, 2026, the stock is trading at USD 418.69 with a total of 543,154 shares traded.
Over the past week, the price has changed by +15.31%, over one month by +21.45%, over three months by +23.21% and over the past year by +137.46%.
Over the past week, the price has changed by +15.31%, over one month by +21.45%, over three months by +23.21% and over the past year by +137.46%.
Is SITM a buy, sell or hold?
Sitime has received a consensus analysts rating of 3.86.
Therefore, it is recommended to buy SITM.
- StrongBuy: 2
- Buy: 3
- Hold: 1
- Sell: 1
- StrongSell: 0
What are the forecasts/targets for the SITM price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 452.2 | 8% |
| Analysts Target Price | 452.2 | 8% |
| ValueRay Target Price | 512 | 22.3% |
SITM Fundamental Data Overview February 07, 2026
P/E Forward = 84.0336
P/S = 38.3344
P/B = 8.2309
P/EG = 3.381
Revenue TTM = 326.7m USD
EBIT TTM = -57.2m USD
EBITDA TTM = -26.7m USD
Long Term Debt = unknown (none)
Short Term Debt = 5.32m USD (from shortTermDebt, two quarters ago)
Debt = 4.43m USD (from shortLongTermDebtTotal, two quarters ago)
Net Debt = -16.8m USD (from netDebt column, last quarter)
Enterprise Value = 10.78b USD (10.79b + Debt 4.43m - CCE 16.8m)
Interest Coverage Ratio = -3.84 (Ebit TTM -57.2m / Interest Expense TTM -14.9m)
EV/FCF = 550.0x (Enterprise Value 10.78b / FCF TTM 19.6m)
FCF Yield = 0.18% (FCF TTM 19.6m / Enterprise Value 10.78b)
FCF Margin = 6.00% (FCF TTM 19.6m / Revenue TTM 326.7m)
Net Margin = -13.13% (Net Income TTM -42.9m / Revenue TTM 326.7m)
Gross Margin = 53.57% ((Revenue TTM 326.7m - Cost of Revenue TTM 151.7m) / Revenue TTM)
Gross Margin QoQ = 56.39% (prev 53.51%)
Tobins Q-Ratio = 8.32 (Enterprise Value 10.78b / Total Assets 1.29b)
Interest Expense / Debt = 129.2% (Interest Expense 5.73m / Debt 4.43m)
Taxrate = 21.0% (US default 21%)
NOPAT = -45.2m (EBIT -57.2m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 11.30 (Total Current Assets 949.3m / Total Current Liabilities 84.0m)
Debt / Equity = 0.00 (Debt 4.43m / totalStockholderEquity, last quarter 1.16b)
Debt / EBITDA = 0.63 (negative EBITDA) (Net Debt -16.8m / EBITDA -26.7m)
Debt / FCF = -0.86 (Net Debt -16.8m / FCF TTM 19.6m)
Total Stockholder Equity = 1.01b (last 4 quarters mean from totalStockholderEquity)
RoA = -3.94% (Net Income -42.9m / Total Assets 1.29b)
RoE = -4.23% (Net Income TTM -42.9m / Total Stockholder Equity 1.01b)
RoCE = -4.72% (EBIT -57.2m / Capital Employed (Total Assets 1.29b - Current Liab 84.0m))
RoIC = -4.68% (negative operating profit) (NOPAT -45.2m / Invested Capital 965.5m)
WACC = 14.99% (E(10.79b)/V(10.80b) * Re(15.0%) + (debt cost/tax rate unavailable))
Discount Rate = 15.0% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 9.56%
[DCF Debug] Terminal Value 45.76% ; FCFF base≈13.1m ; Y1≈8.57m ; Y5≈3.91m
Fair Price DCF = 2.01 (EV 36.2m - Net Debt -16.8m = Equity 52.9m / Shares 26.3m; r=14.99% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: 2.26 | EPS CAGR: 13.87% | SUE: 4.0 | # QB: 8
Revenue Correlation: 26.58 | Revenue CAGR: 13.59% | SUE: 4.0 | # QB: 7
EPS next Quarter (2026-03-31): EPS=1.15 | Chg30d=+0.338 | Revisions Net=+0 | Analysts=7
EPS current Year (2026-12-31): EPS=5.11 | Chg30d=+0.853 | Revisions Net=+0 | Growth EPS=+59.8% | Growth Revenue=+46.3%
EPS next Year (2027-12-31): EPS=6.60 | Chg30d=+0.422 | Revisions Net=+0 | Growth EPS=+29.1% | Growth Revenue=+28.2%
P/S = 38.3344
P/B = 8.2309
P/EG = 3.381
Revenue TTM = 326.7m USD
EBIT TTM = -57.2m USD
EBITDA TTM = -26.7m USD
Long Term Debt = unknown (none)
Short Term Debt = 5.32m USD (from shortTermDebt, two quarters ago)
Debt = 4.43m USD (from shortLongTermDebtTotal, two quarters ago)
Net Debt = -16.8m USD (from netDebt column, last quarter)
Enterprise Value = 10.78b USD (10.79b + Debt 4.43m - CCE 16.8m)
Interest Coverage Ratio = -3.84 (Ebit TTM -57.2m / Interest Expense TTM -14.9m)
EV/FCF = 550.0x (Enterprise Value 10.78b / FCF TTM 19.6m)
FCF Yield = 0.18% (FCF TTM 19.6m / Enterprise Value 10.78b)
FCF Margin = 6.00% (FCF TTM 19.6m / Revenue TTM 326.7m)
Net Margin = -13.13% (Net Income TTM -42.9m / Revenue TTM 326.7m)
Gross Margin = 53.57% ((Revenue TTM 326.7m - Cost of Revenue TTM 151.7m) / Revenue TTM)
Gross Margin QoQ = 56.39% (prev 53.51%)
Tobins Q-Ratio = 8.32 (Enterprise Value 10.78b / Total Assets 1.29b)
Interest Expense / Debt = 129.2% (Interest Expense 5.73m / Debt 4.43m)
Taxrate = 21.0% (US default 21%)
NOPAT = -45.2m (EBIT -57.2m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 11.30 (Total Current Assets 949.3m / Total Current Liabilities 84.0m)
Debt / Equity = 0.00 (Debt 4.43m / totalStockholderEquity, last quarter 1.16b)
Debt / EBITDA = 0.63 (negative EBITDA) (Net Debt -16.8m / EBITDA -26.7m)
Debt / FCF = -0.86 (Net Debt -16.8m / FCF TTM 19.6m)
Total Stockholder Equity = 1.01b (last 4 quarters mean from totalStockholderEquity)
RoA = -3.94% (Net Income -42.9m / Total Assets 1.29b)
RoE = -4.23% (Net Income TTM -42.9m / Total Stockholder Equity 1.01b)
RoCE = -4.72% (EBIT -57.2m / Capital Employed (Total Assets 1.29b - Current Liab 84.0m))
RoIC = -4.68% (negative operating profit) (NOPAT -45.2m / Invested Capital 965.5m)
WACC = 14.99% (E(10.79b)/V(10.80b) * Re(15.0%) + (debt cost/tax rate unavailable))
Discount Rate = 15.0% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 9.56%
[DCF Debug] Terminal Value 45.76% ; FCFF base≈13.1m ; Y1≈8.57m ; Y5≈3.91m
Fair Price DCF = 2.01 (EV 36.2m - Net Debt -16.8m = Equity 52.9m / Shares 26.3m; r=14.99% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: 2.26 | EPS CAGR: 13.87% | SUE: 4.0 | # QB: 8
Revenue Correlation: 26.58 | Revenue CAGR: 13.59% | SUE: 4.0 | # QB: 7
EPS next Quarter (2026-03-31): EPS=1.15 | Chg30d=+0.338 | Revisions Net=+0 | Analysts=7
EPS current Year (2026-12-31): EPS=5.11 | Chg30d=+0.853 | Revisions Net=+0 | Growth EPS=+59.8% | Growth Revenue=+46.3%
EPS next Year (2027-12-31): EPS=6.60 | Chg30d=+0.422 | Revisions Net=+0 | Growth EPS=+29.1% | Growth Revenue=+28.2%